Oral mucosal and salivary proteins

Oral mucosal and salivary proteins represent a diverse collection of molecules, including mucins (MUC5B, MUC7), enzymes (alpha-amylase), and antimicrobial peptides (histatins, lysozyme), that maintain oral homeostasis (NIH, 2021; OMPJ, 2023). These proteins facilitate lubrication, pH buffering, and the initial stages of digestion, while also forming the acquired enamel pellicle to protect tooth surfaces (NIH, 2011; ResearchGate, 2024). In pathological conditions like xerostomia, Sjogren's syndrome, and periodontitis, the composition and flow of these proteins are significantly altered, making them valuable biomarkers for disease monitoring (IntechOpen, 2024; NIH, 2021). While not a single molecular target, specific proteins like mucins are targeted by mucoadhesive drug delivery systems to enhance local bioavailability (NIH, 2021). Secretagogues like pilocarpine are used to stimulate the overall production of these proteins by acting on muscarinic receptors in the salivary glands (OMPJ, 2023). Therapeutic interventions often focus on replacing these proteins with synthetic substitutes or modulating their activity to treat oral infections and inflammatory diseases (IntechOpen, 2024). The study of the salivary proteome, or 'salivanomics,' continues to expand the potential for non-invasive diagnostics and targeted therapies in oral and systemic health (NIH, 2021; OMPJ, 2023).

Other names

Salivary proteomeOral mucus proteinsAcquired enamel pellicle proteinsSalivary biomarkers

Drugs interact with these proteins by stimulating their secretion via muscarinic receptors (e.g., pilocarpine), substituting their lubricating properties with synthetic polymers (e.g., carboxymethylcellulose), or utilizing mucoadhesion to bind to mucins for localized drug delivery (OMPJ, 2023; NIH, 2021).